Duearity AB (publ) (9DS.F)

0.0151 -0.0043 (-22.16%) At close: 08:06AM CEST

Duearity AB (publ)

KrusegrAend 42D
Malmö 212 25
Sweden
46 7 38 14 52 15
https://www.duearity.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Fredrik Westman	CEO & MD	885k	N/A	1972
Mr. Gunnar Telhammar	Chief Financial Officer	N/A	N/A	1961
Arash Golshenas	Chief Technology Officer	N/A	N/A	1984

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help people predict the symptoms and manage their problems. The company was incorporated in 2020 and is based in Malmö, Sweden.

Corporate Governance

Duearity AB (publ)’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.